Cargando…
Disulfiram Produces Potent Anxiolytic-Like Effects Without Benzodiazepine Anxiolytics-Related Adverse Effects in Mice
Disulfiram is an FDA approved drug for the treatment of alcoholism. The drug acts by inhibiting aldehyde dehydrogenase, an enzyme essential to alcohol metabolism. However, a recent study has demonstrated that disulfiram also potently inhibits the cytoplasmic protein FROUNT, a common regulator of che...
Autores principales: | Saitoh, Akiyoshi, Nagayama, Yoshifumi, Yamada, Daisuke, Makino, Kosho, Yoshioka, Toshinori, Yamanaka, Nanami, Nakatani, Momoka, Takahashi, Yoshino, Yamazaki, Mayuna, Shigemoto, Chihiro, Ohashi, Misaki, Okano, Kotaro, Omata, Tomoki, Toda, Etsuko, Sano, Yoshitake, Takahashi, Hideyo, Matsushima, Kouji, Terashima, Yuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940232/ https://www.ncbi.nlm.nih.gov/pubmed/35330835 http://dx.doi.org/10.3389/fphar.2022.826783 |
Ejemplares similares
-
Central amygdala circuit dynamics underlying the benzodiazepine anxiolytic effect
por: Griessner, Johannes, et al.
Publicado: (2018) -
Driving performance and neurocognitive skills of long‐term users of benzodiazepine anxiolytics and hypnotics
por: van der Sluiszen, Nick N.J.J.M., et al.
Publicado: (2019) -
Synthesis, Anticonvulsant, Sedative and Anxiolytic Activities of Novel Annulated Pyrrolo[1,4]benzodiazepines
por: Sorra, Kumaraswamy, et al.
Publicado: (2014) -
Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic
por: Aoki, Yumi, et al.
Publicado: (2023) -
Cognitive Behavioral Therapy Reduces Benzodiazepine Anxiolytics Use in Japanese Patients with Mood and Anxiety Disorders: A Retrospective Observational Study
por: Nakajima, Aiichiro, et al.
Publicado: (2020)